Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Berg becomes GNC COO: General Nutrition Centers names David Berg the Pittsburgh firm's first chief operating officer, promoting him from executive VP, Global Business Development and COO for GNC's international operations. Berg, who will continue to directly report to GNC CEO Joe Fortunato, previously reached the posts of executive VP and COO in seven years with Best Buy International and for two years was president and COO of U.K.-based office equipment firm Danka Business Systems' international division, GNC said June 8

You may also be interested in...



Wisdom stevia GRAS notice

FDA has no objections to Wisdom Natural Brands' affirmation that its stevia-based SweetLeaf Sweetener is generally recognized as safe, according to a letter the firm receives Sept. 1. Wisdom founder Jim May called FDA's validation "a tremendous victory" following research to prove the extract's safety and quality. Other firms including Blue California, Cargill and McNeil Nutritionals have received "no objection" notices from FDA regarding sweeteners made with the stevia preparation rebaudioside A (1"The Tan Sheet" July 6, 2009). SweetLeaf Sweetener was on the market for more than a year before Gilbert, Ariz.-based Wisdom received FDA's response to its GRAS affirmation

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel